Cooperative Agreement AID522A1500002

This Project Grant award, provided by the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), supports a project titled "Advancing Perinatal Genomic Discoveries Through Patient Engagement and Data Sharing." The $754,561 award to Geisinger Clinic, a non-profit integrated healthcare organization in Pennsylvania, aims to enable the translation of genomic data into precision medicine for patients undergoing diagnostic fetal sequencing....

The Global Genomic Medicine Collaborative (G2Mc) received a $109,050 project grant from the National Institutes of Health National Human Genome Research Institute to support its 6th International Conference on Genomic Medicine Implementation in Low Resource Settings. The conference will be held in September-October 2021 in Santiago, Chile and aims to bring together leaders in genomic medicine to discuss best practices for implementing genomics into diverse healthcare delivery systems. A hybrid...

This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $452,375 to The Trustees of Columbia University in the City of New York to develop a platform for rapid and efficient generation of multi-site sequence variants using template-guided gene synthesis. The project aims to advance this synthesis approach by optimizing predictive algorithms, experimental protocols, and robotic automation to produce kilobase-sized DNA constructs up...

This three-year Project Grant from the National Science Foundation's Division of Information and Intelligent Systems under the Computer and Information Science and Engineering program ($600,000) will support the development of new computational methods and software for analyzing collections of genomic variants. Specifically, the grantee, Carnegie Mellon University, will create algorithms and open-source software tools to more accurately construct, compare, and assess the complexity of genome...

This $362,340 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 Human Genome Research) supports a research project titled "EDGE CMT: Identifying Genes that Shape Complex Multigenic Traits within and between Yeast Species". The project aims to apply a new genetic mapping method called CRI-SPA-MAP to systematically identify and analyze causal genes that shape the ability of yeast strains to grow in diverse environmental conditions. The research will be...

This $396,170 Project Grant was awarded on September 17, 2025 by the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) to Syntaxisbio Inc. in Dallas, TX. The project aims to develop an innovative technology using genetic "PUFs" (physical unclonable functions) for precise quantification of cellular age, which will enhance the reproducibility and reliability of experimental outcomes in biomedical research. The key products to be delivered include: 1)...

Sequegenics LLC received a $251,073 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041). The grant supports development of low-cost and scalable methods for creating genomic databases using long-read next-generation DNA sequencing technologies. This aligns with the program's goals of fostering innovation in engineering research. The one-year project period runs from August 1, 2021 through July 31,...

This Project Grant award, provided by the National Human Genome Research Institute (NHGRI) under the Human Genome Research federal grant program (CFDA 93.172), supports the development of advanced methods and computational tools for large-scale genome analysis and alignment. The $633,116 award, with a project period from September 2025 to June 2029, will fund three interconnected aims: Scaling genome alignment and analysis capabilities to accommodate the growing number of vertebrate genomes,...

The National Human Genome Research Institute (NHGRI) awarded a $404,117 Project Grant to Panluminate Inc., a woman-owned small business in Connecticut, to develop CHROMEX30 - a novel variant of the company's proprietary Pan-Expansion Microscopy (PAN-EXM) technology. CHROMEX30 aims to enable high-resolution (sub-10 nm) 3D mapping of genetic organization and molecular biomarkers within cells using standard confocal microscopes. This work builds on Panluminate's previous PAN-EXM developments, which...

This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $3,287,168 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop innovative computational tools and statistical methods for genome-wide association studies (GWAS) of time-to-event (TTE) phenotypes in large biobanks and cohorts. The project aims to overcome current limitations in GWAS of TTE phenotypes, which can identify...